We show that dietary NaNO3 greatly attenuates the development and progression of MASLD and T2DM by rebalancing pro- and anti-inflammatory MoMFs via the modulation of a novel sialin-mediated pathway. Here, SLC17A5 is linked to metabolic dysfunction-associated steatotic liver disease.